Quan Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Quan Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 22, 2025	Avenzo Therapeutics	$60.0M Series B	OrbiMed, SR One	Foresite Capital, Lilly Asia Ventures, Deep Track Capital, Delos Capital, INCE Capital, Longwood Fund, New Enterprise Associates, Sands Capital, Sofinnova Ventures, Surveyor Capital, TF Capital
May 1, 2024	Zenas BioPharma	$200.0M Series C	SR One Capital Management, Tim Xiao, NEA, Norwest Venture Partners	Vivo Capital, ArrowMark Partners, Enavate Sciences, Fairmount, Hermes GPE, Longitude Capital, Pivotal bioVenture Partners, Rock Springs Capital, Superstring Capital, Wellington Management
Mar 26, 2024	Avenzo Therapeutics	$150.0M Series A	Jakob Dupont, Deep Track Capital, New Enterprise Associates, Sands Capital	Foresite Capital, Judith Li, Carl Gordon, Delos Capital, INCE Capital, TF Capital
Dec 6, 2023	Adcentrx Therapeutics	$13.0M Series A Extension	Partners Investment, Quan Capital, Tao Huang	Jeffrey Jonas
Jul 24, 2023	Crescendo Biologics	$32.0M Other Equity	—	Andera Partners, Sonia Benhamida, Sofinnova Partners, Takeda
Jul 1, 2022	Oricell Therapeutics	$120.0M Series B	Qiming Venture Partners, Quan Capital	—
May 10, 2021	Alebund Pharmaceuticals	$60.0M Series B	Quan Capital	3E Bioventures Capital, Lilly Asia Ventures, Med-Fine Capital, Sherpa Healthcare Partners
Jan 1, 2021	Design Therapeutics	$130.0M Series B	Dr. Arsani William	Morgenthaler Ventures, OrbiMed, Samsara BioCapital, SR One, Avoro Capital Advisors, BlackRock, Cormorant Asset Management, Janus Henderson Investors, RA Capital Management, Surveyor Capital, T. Rowe Price Associates, Vivo Capital, Wellington Management, WestRiver Group
Nov 30, 2020	Eluminex Biosciences	$50.0M Series A	Lilly Asia Ventures, Quan Capital	—
Oct 1, 2020	Omphalos Corp	$2.0M Seed	—	Altar Fund, ChainStrategy, RedMars
Sep 28, 2020	MEDx	$51.3M Series B	Nisa Leung	Broad Resources
Mar 1, 2020	Design Therapeutics	$46.0M Series A	SR One	Morgenthaler Ventures, OrbiMed, Samsara BioCapital, Cormorant Asset Management, Stella Xu, WestRiver Group
Oct 3, 2019	Arcellx	$85.0M Series B	Hugo Beekman, Lewis (Rusty) Williams	JVC Investment Partners, LG Technology Ventures, Mirae Asset Capital, Mirae Asset Venture Investment, NEA, Novo Holdings, SR One, Takeda Ventures
Nov 1, 2018	NextCure	$93.0M Series B	Michael Yi, Stella Xu	5AM Ventures, Access Biotechnology, Canaan Partners, Connecticut Innovations, Endeavor Venture Funds, Nextech Invest, OrbiMed, RA Capital, Alexandria Venture Investments, ArrowMark Partners, Bay City Capital, Canaan Partners, Lilly Asia Ventures, NS Investment, Pfizer, Ping An Ventures, Sofinnova Ventures, Surveyor Capital, Taiho Ventures
Apr 1, 2018	Crescendo Biologics	$70.0M Series B	Gilles Nobécourt	Soffinova Partners, Biodiscovery V, EMBL Ventures, Marietta Wu, Takeda Ventures
Mar 1, 2018	Tempest Therapeutics	$70.0M Series B	Versant Ventures, Robert Weisskoff, Stella Xu	F-Prime Capital Partners, Anthony Philippakis, The Column Group, Eight Roads Ventures, Foresite Capital, Lilly Asia Ventures
Jan 1, 2018	Centrexion Therapeutics	$67.0M Series D	Sara Nayeem	Avoro Ventures, David Parkinson, Elliott Sigal, 6 Dimensions Capital, ArrowMark Partners, Efung Capital, InterWest Partners, Stella Xu
Nov 1, 2017	resTORbio	$40.0M Series A	OrbiMed	Fidelity Management & Research Company, Nest.Bio Ventures, Rock Springs Capital
Aug 1, 2017	ARMO BioSciences	$67.0M Series C	Qiming Venture Partners	Cultivation Capital, Khosla Ventures, NanoDimension, Westlake Village BioPartners, Y Combinator, Mark Pincus, Celgene, DAG Ventures, Min Cui, Google Ventures, HBM Healthcare Investments, Kleiner Perkins, NanoDimension, OrbiMed, Stella Xu, RTW Investments, Sequoia Capital